FDA Shuts Down Thousands Of Illegal Internet PharmaciesMain Category: Regulatory Affairs / Drug Approvals
Also Included In: Public Health | Litigation / Medical Malpractice | Pharmacy / Pharmacist
Article Date: 05 Oct 2012
The U.S. Food and Drug Administration has taken charge of a dangerous upturn in illegal online pharmacies that sell dangerous, unapproved medications to consumers.
In collaboration with international regulatory and law enforcement agencies, the FDA took legal action against more than 4,100 internet pharmacies via criminal charges, seizure of illegal products, and removal of websites.
This noteworthy bulletin comes directly in the midst of the 5th annual International Week of Action (IIWA), a joint venture to tackle the online sale and distribution of phony and illegal drugs. This year's objective, Operation Pangea V, resulted in the closing of over 18,000 unauthorized pharmacy websites and the confiscation of around $10.5 million worth of pharmaceuticals around the globe. The goal of this effort, involving different officials from 100 countries, was to pinpoint producers and suppliers of illegal medical devices as well as pharmaceutical products and remove them from the market.
FDA Commissioner Margaret A. Hamburg, M.D., says:
"Consumers in the United States and around the world face a real threat from Internet pharmacies that illegally sell potentially substandard, counterfeit, adulterated or otherwise unsafe medicines. This week's efforts show that strong international enforcement efforts are required to combat this global public health problem. The FDA is committed to joining forces to protect consumers from the risks these websites present."
To accompany this international effort, the FDA launched a national campaign to educate Americans about the dangers of purchasing prescription medications online. "BeSafeRX, know your Online Pharmacy", focuses on awareness about the health risks of using illicit pharmacies and how consumers can protect themselves.
The FDA targeted websites who were selling illegal and potentially dangerous medications. These medications could be damaging to the public because many of them contained active ingredients that should only be used under the guidance of a certified healthcare practitioner, or ingredients that have previously been removed from the market due to safety issues.
Illegal medicines that were being distributed included:
First, the FDA sent letters of warning to the managers of 4,100 recognized websites. Second, the agency sent notices to registries, internet service providers, and domain name registries (DNRs) notifying them that the products for sale on their sites were in breach of U.S. law. Currently, the FDA is working with all involved countries worldwide to address the remaining websites that continue to operate by selling illegal medications to U.S. consumers.
John Roth, director of the FDA's Office of Criminal Investigation, concludes:
"Internet pharmacies that illegally sell unapproved, counterfeit, or potentially adulterated or substandard drugs are an inherently international crime problem. The FDA is pleased to work with INTERPOL, the international police agency, to fight this problem. Because these criminals do not respect international borders, the international coordinated law enforcement response represented by Operation Pangea demonstrates that international cooperation is the best way to protect the American public from the risk of unsafe drugs."
During Operation Pangea V, the FDA screened all drug products that came in through international mail facilities during the IIWA. Findings show products such as antibiotics, antidepressants, and other medications to treat high cholesterol, diabetes, and high blood pressure were on their way to U.S. purchasers. Several of those products were potentially dangerous if taken without the supervision of a health care practitioner, or if the products had previously been removed from the market for safety issues.
Written by Kelly Fitzgerald
Copyright: MediLexicon International Ltd
Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today